Shares of Varian Medical Systems VAR were flat in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share decreased 1.72% year over year to $1.14, which beat the estimate of $1.10.
Revenue of $778,800,000 decreased by 6.04% year over year, which missed the estimate of $842,980,000.
Looking Ahead
Varian Medical Systems hasn't issued any earnings guidance for the time being.
Varian Medical Systems hasn't issued any revenue guidance for the time being.
Recent Stock Performance
52-week high: $176.19
52-week low: $89.62
Price action over last quarter: Up 1.71%
Company Profile
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.